Edition:
United Kingdom

People: Alkermes Plc (ALKS.OQ)

ALKS.OQ on NASDAQ Stock Exchange Global Select Market

22.30USD
13 Sep 2019
Change (% chg)

$-0.32 (-1.41%)
Prev Close
$22.62
Open
$22.52
Day's High
$22.83
Day's Low
$21.67
Volume
913,050
Avg. Vol
534,041
52-wk High
$45.12
52-wk Low
$19.37

Landine, Michael 

Mr. Michael J. Landine is Senior Vice President - Corporate Development, Chief Risk Officer of the Company. Prior to assuming his current positions, from September 2011 to March 2018, Mr. Landine served as Senior Vice President, Corporate Development of Alkermes, Inc. From May 2007 to September 16, 2011, Mr. Landine served as Senior Vice President, Corporate Development of Alkermes, Inc. From March 1999 until May 2007, Mr. Landine served as Vice President, Corporate Development of Alkermes, Inc. From March 1988 until June 1998, he was Chief Financial Officer and Treasurer of Alkermes, Inc. Mr. Landine is a member of the board of directors of Kopin Corporation, a publicly traded manufacturer of components for electronic products, and was a member of the board of directors of ECI Biotech, a privately held protein sensor company and GTC Biotherapeutics, Inc., a publicly traded biotechnology company. Mr. Landine was previously a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

9,380,490

James Frates

2,828,540

Elliot Ehrich

3,547,020

Iain Brown

--

David Gaffin

--

Michael Landine

--
As Of  31 Dec 2017